Cargando…
Targeting chaperonin containing TCP1 (CCT) as a molecular therapeutic for small cell lung cancer
Identifying new druggable targets is desired to meet the needs for effective cancer treatments. To this end, we previously reported the efficacy of a therapeutic peptide called CT20p that displays selective cytotoxicity through inhibition of a multi-subunit, protein-folding complex called Chaperonin...
Autores principales: | Carr, Ana C., Khaled, Amr S., Bassiouni, Rania, Flores, Orielyz, Nierenberg, Daniel, Bhatti, Hammad, Vishnubhotla, Priya, Manuel, J. Perez, Santra, Santimukul, Khaled, Annette R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746381/ https://www.ncbi.nlm.nih.gov/pubmed/29299146 http://dx.doi.org/10.18632/oncotarget.22681 |
Ejemplares similares
-
Chaperonin containing TCP-1 (CCT/TRiC) is a novel therapeutic and diagnostic target for neuroblastoma
por: Cox, Amanda, et al.
Publicado: (2022) -
Investigating Chaperonin-Containing TCP-1 subunit 2 as an essential component of the chaperonin complex for tumorigenesis
por: Showalter, Anne E., et al.
Publicado: (2020) -
PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer
por: Flores, Orielyz, et al.
Publicado: (2017) -
Chaperonin-Containing TCP1 Complex (CCT) Promotes Breast Cancer Growth Through Correlations With Key Cell Cycle Regulators
por: Ghozlan, Heba, et al.
Publicado: (2021) -
The malaria parasite chaperonin containing TCP-1 (CCT) complex: Data integration with other CCT proteomes
por: Wilkinson, Mark D., et al.
Publicado: (2022)